vs
Side-by-side financial comparison of Apyx Medical Corp (APYX) and UNITED SECURITY BANCSHARES (UBFO). Click either name above to swap in a different company.
Apyx Medical Corp is the larger business by last-quarter revenue ($19.2M vs $13.5M, roughly 1.4× UNITED SECURITY BANCSHARES). UNITED SECURITY BANCSHARES runs the higher net margin — 25.2% vs -6.8%, a 32.0% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs 13.6%). UNITED SECURITY BANCSHARES produced more free cash flow last quarter ($19.8M vs $-2.8M). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs 3.0%).
Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.
United Security Bancshares is a bank holding company headquartered in Fresno, California. It operates 11 branches.
APYX vs UBFO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $19.2M | $13.5M |
| Net Profit | $-1.3M | $3.4M |
| Gross Margin | 62.6% | — |
| Operating Margin | 0.1% | 31.5% |
| Net Margin | -6.8% | 25.2% |
| Revenue YoY | 34.7% | 13.6% |
| Net Profit YoY | 71.9% | 36.8% |
| EPS (diluted) | — | $0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.2M | $13.5M | ||
| Q3 25 | $12.9M | $14.0M | ||
| Q2 25 | $11.4M | $12.6M | ||
| Q1 25 | $9.4M | $13.7M | ||
| Q4 24 | $14.2M | $11.9M | ||
| Q3 24 | $11.5M | $13.8M | ||
| Q2 24 | $12.1M | $13.0M | ||
| Q1 24 | $10.2M | $12.8M |
| Q4 25 | $-1.3M | $3.4M | ||
| Q3 25 | $-2.0M | $4.0M | ||
| Q2 25 | $-3.8M | $2.2M | ||
| Q1 25 | $-4.2M | $2.7M | ||
| Q4 24 | $-4.6M | $2.5M | ||
| Q3 24 | $-4.7M | $3.8M | ||
| Q2 24 | $-6.6M | $4.3M | ||
| Q1 24 | $-7.6M | $4.2M |
| Q4 25 | 62.6% | — | ||
| Q3 25 | 64.4% | — | ||
| Q2 25 | 62.3% | — | ||
| Q1 25 | 60.1% | — | ||
| Q4 24 | 63.0% | — | ||
| Q3 24 | 60.5% | — | ||
| Q2 24 | 61.7% | — | ||
| Q1 24 | 58.1% | — |
| Q4 25 | 0.1% | 31.5% | ||
| Q3 25 | -6.5% | 40.3% | ||
| Q2 25 | -22.6% | 24.0% | ||
| Q1 25 | -32.4% | 27.5% | ||
| Q4 24 | -21.4% | 27.5% | ||
| Q3 24 | -31.6% | 37.1% | ||
| Q2 24 | -45.7% | 46.4% | ||
| Q1 24 | -64.6% | 45.9% |
| Q4 25 | -6.8% | 25.2% | ||
| Q3 25 | -15.4% | 28.7% | ||
| Q2 25 | -33.2% | 17.2% | ||
| Q1 25 | -44.0% | 19.6% | ||
| Q4 24 | -32.5% | 20.9% | ||
| Q3 24 | -40.9% | 27.7% | ||
| Q2 24 | -54.0% | 33.0% | ||
| Q1 24 | -74.0% | 32.6% |
| Q4 25 | — | $0.18 | ||
| Q3 25 | — | $0.23 | ||
| Q2 25 | — | $0.13 | ||
| Q1 25 | — | $0.16 | ||
| Q4 24 | — | $0.14 | ||
| Q3 24 | — | $0.22 | ||
| Q2 24 | $-0.19 | $0.25 | ||
| Q1 24 | $-0.22 | $0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | $264.2M |
| Total DebtLower is stronger | $37.5M | — |
| Stockholders' EquityBook value | $14.5M | $139.7M |
| Total Assets | $66.8M | $1.2B |
| Debt / EquityLower = less leverage | 2.58× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.7M | $264.2M | ||
| Q3 25 | $25.1M | $211.1M | ||
| Q2 25 | $29.3M | $199.5M | ||
| Q1 25 | $31.0M | $198.4M | ||
| Q4 24 | $31.7M | $216.9M | ||
| Q3 24 | $28.0M | $216.8M | ||
| Q2 24 | $32.7M | $166.3M | ||
| Q1 24 | $37.3M | $168.6M |
| Q4 25 | $37.5M | — | ||
| Q3 25 | $37.5M | — | ||
| Q2 25 | $37.5M | — | ||
| Q1 25 | $37.5M | — | ||
| Q4 24 | $37.5M | — | ||
| Q3 24 | $37.5M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $14.5M | $139.7M | ||
| Q3 25 | $5.8M | $137.4M | ||
| Q2 25 | $7.3M | $134.3M | ||
| Q1 25 | $10.5M | $132.9M | ||
| Q4 24 | $14.2M | $130.4M | ||
| Q3 24 | $11.0M | $132.9M | ||
| Q2 24 | $14.7M | $127.3M | ||
| Q1 24 | $20.3M | $124.2M |
| Q4 25 | $66.8M | $1.2B | ||
| Q3 25 | $57.4M | $1.2B | ||
| Q2 25 | $58.2M | $1.2B | ||
| Q1 25 | $60.2M | $1.2B | ||
| Q4 24 | $64.8M | $1.2B | ||
| Q3 24 | $60.7M | $1.3B | ||
| Q2 24 | $65.4M | $1.2B | ||
| Q1 24 | $70.7M | $1.2B |
| Q4 25 | 2.58× | — | ||
| Q3 25 | 6.41× | — | ||
| Q2 25 | 5.17× | — | ||
| Q1 25 | 3.57× | — | ||
| Q4 24 | 2.64× | — | ||
| Q3 24 | 3.40× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | $22.1M |
| Free Cash FlowOCF − Capex | $-2.8M | $19.8M |
| FCF MarginFCF / Revenue | -14.6% | 146.0% |
| Capex IntensityCapex / Revenue | 1.4% | 16.8% |
| Cash ConversionOCF / Net Profit | — | 6.46× |
| TTM Free Cash FlowTrailing 4 quarters | $-9.1M | $36.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.5M | $22.1M | ||
| Q3 25 | $-3.5M | $7.0M | ||
| Q2 25 | $-1.2M | $8.7M | ||
| Q1 25 | $-702.0K | $3.0M | ||
| Q4 24 | $-2.9M | $19.6M | ||
| Q3 24 | $-4.4M | $5.4M | ||
| Q2 24 | $-4.3M | $2.3M | ||
| Q1 24 | $-6.3M | $7.4M |
| Q4 25 | $-2.8M | $19.8M | ||
| Q3 25 | $-4.1M | $6.1M | ||
| Q2 25 | $-1.5M | $8.1M | ||
| Q1 25 | $-757.0K | $2.9M | ||
| Q4 24 | $-3.2M | $18.6M | ||
| Q3 24 | $-4.6M | $5.3M | ||
| Q2 24 | $-4.6M | $2.0M | ||
| Q1 24 | $-6.4M | $7.0M |
| Q4 25 | -14.6% | 146.0% | ||
| Q3 25 | -31.5% | 43.7% | ||
| Q2 25 | -13.2% | 64.3% | ||
| Q1 25 | -8.0% | 21.2% | ||
| Q4 24 | -22.4% | 156.0% | ||
| Q3 24 | -40.0% | 38.1% | ||
| Q2 24 | -38.0% | 15.5% | ||
| Q1 24 | -62.2% | 54.8% |
| Q4 25 | 1.4% | 16.8% | ||
| Q3 25 | 4.0% | 6.0% | ||
| Q2 25 | 2.3% | 4.6% | ||
| Q1 25 | 0.6% | 0.9% | ||
| Q4 24 | 1.7% | 8.7% | ||
| Q3 24 | 1.3% | 0.7% | ||
| Q2 24 | 2.4% | 2.2% | ||
| Q1 24 | 0.3% | 3.6% |
| Q4 25 | — | 6.46× | ||
| Q3 25 | — | 1.73× | ||
| Q2 25 | — | 4.01× | ||
| Q1 25 | — | 1.13× | ||
| Q4 24 | — | 7.87× | ||
| Q3 24 | — | 1.40× | ||
| Q2 24 | — | 0.54× | ||
| Q1 24 | — | 1.79× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
